Clinical Trial Update: Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the combination of radiosurgery and nivolumab for brain metastases in various cancers, with completion reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Clear Cell Renal Cell Carcinoma
• Melanoma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• OPDIVO (nivolumab)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Clear-Cell Metastatic Renal Cell Carcinoma, Non Small Cell Lung Cancer Metastatic | Phase 2 | Status: COMPLETED